STIOLTO® RESPIMAT® (tiotropium bromide) Available in US | BI US STIOLTO® RESPIMAT® (tiotropium bromide) Available in US | BI US Read more about the newly available medication for COPD, STIOLTO RESPIMAT, proven to support both treatment and management of the disease.
Results from Phase II MASH trial announced at EASL 2024 Results from Phase II MASH trial announced at EASL 2024 Boehringer Ingelheim announced results from Phase II trial in metabolic dysfunction-associated steatohepatitis (MASH) at EASL 2024